US Patent Issued to EMPIRICO on July 7 for "Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases" (California, Wisconsin Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,165, issued on July 7, was assigned to EMPIRICO INC. (San Diego).

"Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases" was invented by Omri Gottesman (San Diego), Shannon Bruse (San Diego), Brian Cajes (San Diego), David Lewis (Madison, Wis.) and David Rozema (Cross Plains, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compositions comprising an oligonucleotide that targets Angiopoietin-like 4 (ANGPTL4). The oligonucleotide may include a small interfering RNA (siRNA) or an antisense oligonucleotide (ASO). Also provided herein are methods of treating a metabolic or cardiovascular disorder by providing a...